Canopy Immuno-Therapeutics is a preclinical-stage biotech company developing a new class of biologics using its proprietary Reverse-Immunization platform to provide non-immunosuppressive treatments for autoimmune, allergic, and other antibody-mediated conditions
Canopy Immuno-Therapeutics is a preclinical-stage biotech company developing a new class of biologics using its proprietary Reverse-Immunization platform to provide non-immunosuppressive treatments for autoimmune, allergic, and other antibody-mediated conditions.